Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Zomedica Corp.
Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health
July 18, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Announces New Global Manufacturing & Distribution Center
July 07, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared
July 06, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team
June 28, 2022
From
Zomedica Corp.
Via
AccessWire
Topics
Supply Chain
Exposures
Supply Chain
Tickers
ZOM
Zomedica to Participate in Panel Discussion at Animal Health Investment Forum
June 21, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared
June 15, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses
June 13, 2022
From
Zomedica Corp.
Via
AccessWire
Topics
Law Enforcement
Exposures
Legal
Tickers
ZOM
Zomedica to Present at JMP Securities Life Sciences Conference
June 08, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary
June 02, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line
May 19, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans
May 16, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues
May 10, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship
May 04, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica to Present at H.C. Wainwright Global Investment Conference
April 27, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica's Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse Association
April 13, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Announces Launch of eACTH Assay for Truforma(R) Platform
April 04, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results
March 01, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross Margin
February 25, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Appoints Adrian Lock to Lead Sales Organization
February 15, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Announces Management Team Additions
February 09, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Provides Updates on PulseVet Sales & Marketing Integration and Marketing Activities for the First Quarter of 2022
January 27, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica CEO Provides Update to Shareholders
January 10, 2022
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica to Present at H.C. Wainwright BioConnect 2022 Conference
December 15, 2021
From
Zomedica Corp.
Via
AccessWire
Tickers
ZOM
Zomedica Announces Third Quarter 2021 Financial Results
November 12, 2021
From
Zomedica Corp.
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
ZOM
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.